Recent Headlines
Within Biotechnology
Bioscience Americas Senior Scientific Advisor Presents at Major FDA Public Hearing
Dr. Leslie Miller backs the creation of a Registry of Cell Therapy to provide guidelines for stem cell use in therapies and treatments. - October 17, 2016 - Bioscience Americas
HyperFlux™ PRO Plus Now Available in Europe
Full Raman spectroscopy system joins Tornado Spectral Systems' stand-alone spectrometers. - October 14, 2016 - Tornado Spectral Systems
Oxford AHSN Recognizes the SGC with Its Annual Public-Private Collaboration Award
Pioneering work to accelerate drug discovery earned the SGC the 2016 Oxford Academic Health Science Network (Oxford AHSN) collaboration award. - October 11, 2016 - The SGC
Bioscience Americas Sponsors "Solutions for a Healthier World Foundation"
Independent not-for-profit will provide stem cell therapies for the less fortunate. - October 06, 2016 - Bioscience Americas
Stroke Patients Able to Walk Again After Stem Cell Therapy by Dr. Henderson at Regenerative Medical Group
Dr. Bryn J. Henderson and his Regenerative Medical Group can help stroke patients return to normal life as much as possible through advanced stem cell therapy. The touching story of Bill Dendiu, stroke survivor, who was able to walk again after innovative procedures at RMG gives hope to many patients. - October 06, 2016 - Regenerative Medical Group
Smart Wearables: The Future of Personalized Healthcare
Roots Analysis has announced the addition of the “Smart Wearables in Healthcare, 2016-2030” report to its list of offerings. The report provides a comprehensive analysis of the current market landscape with respect to key players and specific applications of the diverse range of... - October 03, 2016 - Roots Analysis
Children with High Grade Brain Tumors Will Soon be Able to Receive Cutting Edge Oncolytic Virus Therapy
Re-engineered Polio Virus with Dramatic Response in Adults to be Made Available to Children in a Phase 1 Clinical Trial Jointly Funded by The Andrew McDonough B+ Foundation and Solving Kids’ Cancer. - September 30, 2016 - Solving Kids' Cancer
Spherium Biomed Starts Efficacy Trial Cyclatop for the Treatment of Atopic Dermatitis in Adults and Infants
The clinical trial is a pilot study (the Cyclatop study) for the evaluation of SP14019-F-01 topical solution for the treatment of atopic dermatitis. It is designed to investigate the safety, tolerability, pharmacokinetics and efficacy of SP14019-F-01 across all group ages for the treatment of mild... - September 29, 2016 - Spherium Biomed
American Science and Technology Awarded Second New Patent
New Patented Process Can Produce High Quality Pulp as Well as Desirable Bio-Renewable Materials - September 29, 2016 - American Science and Technology
STATIC™ – New Video Broadcast Series Uncovering “The Good, The Bad and the Ugly” of Nutritional Products
Virun® Nutra-BioSciences® Creates New Series of Video Broadcasts Called STATIC, Focusing on Nutrition Found in Finished Products. - September 27, 2016 - VIRUN
Spaulding Clinical Research Named “Best Phase I Drug Development CRO”
International Life Sciences continue to have a global impact and be captivated by daily breakthroughs that focus on companies, departments, and individuals who truly deserve to be identified as unique in their industry. As such, Spaulding Clinical Research keeps conducting tests and research, embracing the most advanced technology to forge ahead into clinical research and biometric solutions. - September 24, 2016 - Spaulding Clinical Research, LLC
Quorum Innovations Announces Availability of Human Microbiome Therapeutics to Treat Common Skin Conditions and Metabolic Disorders
Probiomic Therapeutics™ for Eczema, Atopic Dermatitis, Eosinophilic Esophagitis (EoE), Metabolic Disorders - September 24, 2016 - Quorum Innovations
AUM LifeTech's Self-Delivering FANA Antisense Oligonucleotides to be Distributed by MoBiTec Germany
AUMsilence self-delivering oligos achieve highly efficient and potent antisense-based gene knockdown. No need to use toxic transfection reagents. Especially designed for primary cells and very difficult-to-transfect cell types. - September 24, 2016 - MoBiTec GmbH
For Lentivirus Production: TransIT®-Lenti Transfection Reagent, Available from MoBiTec, Germany
TransIT®-Lenti Transfection Reagent, manufactured by Mirus Bio, US, is designed to enhance delivery of packaging and transfer vectors to adherent HEK 293T cell types and increase recombinant lentivirus production. - September 23, 2016 - MoBiTec GmbH
MR Solutions to Supply Cryogen-Free 7T Simultaneous PET-MR Preclinical Imaging System for the Study of Alzheimer’s and Stroke at the University of Southern California
MR Solutions has received an order for a high-powered 7T, cryogen-free, preclinical PET-MRI multi-modality imaging system from the newly formed pre-clinical imaging resource at the Zilkha Neurogenetic Institute (ZNI) at the Keck School of Medicine of the University of Southern California... - September 22, 2016 - MR Solutions
Batavia Biosciences Receives Grant to Develop New Vaccine Against Rotavirus
Batavia Biosciences received an $8 million grant from the Bill & Melinda Gates Foundation to develop a low cost manufacturing process to bring an affordable rotavirus vaccine to the global health market. This vaccine aims to save many young children’s lives worldwide. - September 21, 2016 - Batavia Biosciences
ALPCO Releases Versatile and Economical Chemiluminescent Plate Reader
ALPCO has launched its new STELLUX® Chemiluminescent Plate Reader, an economical and versatile system for any size lab. - September 20, 2016 - ALPCO
Bioscience Americas Announces New Cellular Immunotherapy Treatment
The treatment represents a breakthrough therapy that incorporates advanced stem cell protocols. - September 20, 2016 - Bioscience Americas
HDAC Inhibitors: Controlling Disease Propagation by Regulating Gene Expression
Roots Analysis has announced the addition of the “HDAC Inhibitors Market, 2016-2026” report to their list of offerings. It provides a comprehensive study on the current landscape of the evolving pipeline in this area. With five commercialized products, the market has gained the... - September 19, 2016 - Roots Analysis
SE3D Awarded Phase Two NSF Grant
SE3D, a company leading innovation in bioscience education and technology, announced today that it has been awarded the Small Business and Innovation Research (SBIR) Phase II grant from the National Science Foundation (NSF). The NSF SBIR grant is awarded to organizations who create innovative... - September 16, 2016 - SE3D
We All Want to Live in a Yellow Submarine at Virun’s SupplySide West Booth
Go under the sea in a yellow submarine and cast your vote for the next Omega-3 Smoothie - September 15, 2016 - VIRUN
Recursion Pharmaceuticals Receives Fast-Track SBIR Grant to Study Age-Related Disease
Recursion Pharmaceuticals, an exciting biotech company located in the University of Utah’s Research Park, today announced a $223,000 Phase I Small Business Innovation Research award from the National Institutes of Health (NIH) via the National Institute on Aging (NIA). The award, which has... - September 15, 2016 - Recursion Pharmaceuticals
The Journal Headache Reports That electroCore’s Non-Invasive Vagus Nerve Stimulator is an Effective Bioelectric Medicine for Episodic Cluster Headache
In a multi-centered, sham-controlled study conducted in the United States, episodic cluster headache patients using the gammaCore non-invasive vagus nerve stimulation device (nVNS) had a significant and clinically meaningful benefit within 15 minutes of the treatment of the attack, as compared with... - September 14, 2016 - electroCore
CHI's 8th Annual SCOPE: Summit for Clinical Ops Executives Returns to Miami, January 24-26, 2017
1,200+ Executives to gather for solutions on various aspects of clinical trial planning and management at 13 co-located conferences and 2 symposia - September 13, 2016 - Cambridge Healthtech Institute
The SGC Releases Enabling Information to Accelerate Drug Discovery
Data packages provide a crucial link between human genetics and disease biology to accelerate drug discovery in cancer and malaria. - September 13, 2016 - The SGC
Novel Drugs and Devices to Lower Intraocular Pressure: Revolutionary Advances Poised to Grow at a Rapid Rate
Roots Analysis has announced the addition of the “Novel Drugs and Devices to Lower Intraocular Pressure, 2016 - 2026” report to its list of offerings. The report provides a detailed study on the current market landscape, future trends and applications of these novel treatment options. - September 12, 2016 - Roots Analysis
CRISPR/Cas9 - Request a Free Sample for Your Genome Editing Research
The use of CRISPR/Cas9 has emerged as a powerful method for genome editing that can be delivered in multiple formats. MoBiTec together with Mirus Bio provide solutions to address delivery of Cas9 and guide RNA in plasmid, RNA, or RNP format. - September 10, 2016 - MoBiTec GmbH
MR Solutions Accelerates Sales of Its Preclinical Multi-Modality, High Field, Cryogen Free Scanners
Simultaneous and sequential PET-MR imaging systems with proven reference sites on show at 2016 WMIC in New York. - September 08, 2016 - MR Solutions
Tornado Spectral Systems to Present and Exhibit at SciX 2016
Leading manufacturer of optical spectrometers and Raman spectroscopy systems to highlight innovative technologies at annual SciX conference. - September 08, 2016 - Tornado Spectral Systems
Silicone Suction Hose from AdvantaPure(R) is Now NSF Listed; Provides an Increased Level of Quality Assurance
AdvantaPure’s APSW silicone suction hose now boasts an NSF listing (NSF-51), giving users reassurance for the product’s compatibility with food, beverage and other clean applications. APSW is reinforced with a helical stainless steel wire and layers of fabric and silicone to handle both suction and discharge applications. The hose is available in smooth or convoluted O.D. styles, withstands temperatures up to 350 degrees F, and may be sterilized using several different methods. - September 02, 2016 - AdvantaPure
Dextra UK Launched the World's Largest Commercial Glycan Array, Marketed in Germany and Other Countries Through Its Authorized Distributor MoBiTec GmbH
Dextra's Glycan Array Kit is a valuable tool for use in determining the glycan binding profile of proteins, eukaryotic cells, viruses, spores, bacteria, and parasites. It features 104 unique glycans carefully selected from cutting-edge libraries. - September 02, 2016 - MoBiTec GmbH
NuvOx Pharma Awarded NIH Grant to Develop Technology to Treat Endocarditis
NuvOx Pharma, a Tucson based biotechnology company, has been awarded a grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health for $243,164.00 entitled, “Fibrin Targeted Microbubbles and Ultrasound for... - August 27, 2016 - NuvOx Therapeutics
ÉlpisÉremo’s Breakthrough Technology to Transcend Stem Cell Regenerative Therapy
ÉlpisÉremo succeeds in the world’s first development of a revolutionary technology comparable to the “Med-Bay” seen in the movie "Elysium." - August 26, 2016 - Elpis Eremo Inc.
Clinical Trial Supplies
Clinical Trial Supplies 2nd Annual Symposium will be held in Brussels on the 20th and 21st of October 2016. CTS is a meeting dedicated in exploring the medical supplies required for Clinical Trials and Operations. Presented by prestigious pharmaceutical and biotechnology companies globally engaged... - August 25, 2016 - Business Dialogue
PBTF Unites with We Can to Form California Chapter
The We Can Pediatric Brain Tumor Network is now the California Chapter of the Pediatric Brain Tumor Foundation. - August 25, 2016 - Pediatric Brain Tumor Foundation
FDA Allows NuvOx Pharma’s IND to Initiate Phase Ib Clinical Trial in Stroke
Evan Unger, MD, President and CEO of NuvOx, announced that the FDA has allowed an investigational new drug application (IND) for NVX-208 (dodecafluoropentane emulsion) to be tested in a Phase Ib trial in stroke patients. The trial will be performed at the University of Arkansas Medical System in... - August 22, 2016 - NuvOx Therapeutics
Non-Insulin Therapies for Diabetes: Growth Drivers and Future Outlook
Roots Analysis has announced the addition of “Non-Insulin Therapies for Diabetes: GLP-1 Agonists, DPP4 Inhibitors and SGLT2 Inhibitors, 2016 - 2026” report to its portfolio. The report provides a comprehensive analysis of the current market landscape of GLP-1 agonists, DPP4 inhibitors... - August 22, 2016 - Roots Analysis
MiTeGen Awarded 2016 Inc. 5000 Recognition
MiTeGen LLC, a provider of innovative consumables for protein crystallization and X-ray diffraction to academic, pharmaceutical, industrial and government researchers around the world, has been awarded a listing on the 2016 Inc. 5000. The Inc.5000 recognizes the country's top 5000 fastest-growing private companies. - August 18, 2016 - MiTeGen, LLC
ALPCO’s New and Improved Adiponectin ELISAs Allow Researchers to Confidently Study Type 2 Diabetes
ALPCO has released new and improved versions of their Total Adiponectin and HMW & Total Adiponectin ELISAs which allow researchers to confidently measure adiponectin for the study of high molecular weight (HMW) to total ratios. - August 17, 2016 - ALPCO
KinderPharm to Celebrate Grand Opening of New Exton Office
Pennsylvania Elected Officials to Participate in Ribbon-Cutting Ceremony and Grand Opening Event; KinderPharm is pleased to announce that it will hold a Grand Opening event and Ribbon-Cutting ceremony for its new office at 100 Arrandale Blvd., Exton, Pennsylvania on Friday, August 26th from 1 p.m. to 3 p.m. The event will feature a ribbon-cutting ceremony at 1 p.m., food and refreshments, and industry networking. - August 16, 2016 - KinderPharm LLC
CellectCell, Inc. Announces Georgia Research Alliance Phase IIB Funding for the Commercialization of Novel Label-Free Cell Isolation Technology
CellectCell, Inc., a company that develops novel cell isolation and purification technology, announced today the completion of milestones related to its Phase IIA grant and receipt of Phase IIB grant funding from the Georgia Research Alliance (GRA). CellectCell’s initial focus is the... - August 12, 2016 - CellectCell, Inc.
MR Solutions Receives Queen’s Award from Lord Lieutenant of Surrey
MR Solutions has received the prestigious Queen’s Award for Enterprise from the Lord Lieutenant of Surrey at their Guildford headquarters in July to mark their achievement for innovation. MR Solutions received the accolade for the development and commercial success of its preclinical... - August 11, 2016 - MR Solutions
TruInject Founder Gabrielle Rios Receives Nomination for Innovator of the Year from the Orange County Business Journal
TruInject Medical Corp™ is pleased to announce the nomination of Innovator of the Year by the Orange County Business Journal. - August 09, 2016 - Truinject Medical Corp.
Titanium Healthcare, Inc. Provides Update Regarding Current Ventures
Titanium Healthcare, Inc. (OTCQB: TIHC) ("Titanium") today announced the following updates: Odin Titanium previously announced the formation of Odin Applied Research Laboratories (“OARL”) to conduct a joint venture with Odin Industries, LLC. On September 11, 2015. The closing... - August 01, 2016 - Titanium Healthcare, Inc
Titanium Healthcare, Inc. Provides Update Regarding Annual 10K Report
Titanium Healthcare, Inc. (OTCQB: TIHC) ("Titanium") today announced that the continued delay in the filing of the Company's annual report on Form 10-K, which was due on April 15, 2016, is due to the challenges surrounding the following, which management has been addressing: -Recent... - July 31, 2016 - Titanium Healthcare, Inc
Fluorescent Cell Organelle Stains - Free Brochure Launched by MoBiTec GmbH
Fluorescent molecules and conjugates are invaluable tools in modern medical and biological laboratories. Cell-permeant fluorophores help reveal the localization of intracellular organelles and structures in live cells with minimal impairment. - July 30, 2016 - MoBiTec GmbH
Braincure Biotech Study Indicates New Target for Combating Alzheimer’s
A team of researchers led by Sírnir Thorsson has established that the protein GPR3 could be instrumental in relieving cognitive deficits and mitigating the production of "amyloid plaques." - July 21, 2016 - BrainCure Biotech
Braincure Biotech Publishes Two New Reports
With more than 90 medicines in clinical trials or awaiting approval and knowledge of Alzheimer’s increasing, patients and caretakers look towards the future with high spirits. - July 21, 2016 - BrainCure Biotech
MR Solutions Receives Queen’s Award for Enterprise at Buckingham Palace
MR Solutions, the Surrey-based preclinical imaging company, received royal approval when attending a reception at Buckingham Palace to receive the prestigious Queen’s Award for Enterprise (Innovation). This was achieved in recognition of their development of the world’s first commercial... - July 21, 2016 - MR Solutions
MiTeGen Announces NANUQ™, an Automated High-Speed Cryocooling Device
MiTeGen LLC, a provider of innovative consumables for protein crystallization and X-ray diffraction to academic, pharmaceutical, industrial and government researchers around the world, announced the launch of their NANUQ™ automated, high-speed, cryocooling device for improved cryopreservation of small samples. - July 20, 2016 - MiTeGen, LLC